Sanofi turns to artificial intelligence to beat flu
The French drugmaker Sanofi has teamed up with a US biotech group to use artificial intelligence in an effort to develop more effective flu vaccines.
The French drugmaker Sanofi has teamed up with a US biotech group to use artificial intelligence in an effort to develop more effective flu vaccines.